By Professor Glenda Halliday

Journal articles

Gallagher MD; Suh E; Grossman M; Elman L; McCluskey L; Van Swieten JC; Al-Sarraj S; Neumann M; Gelpi E; Ghetti B; Rohrer JD; Halliday G; Van Broeckhoven C; Seilhean D; Shaw PJ; Frosch MP; Alafuzoff I; Antonell A; Bogdanovic N; Brooks W; Cairns NJ; Cooper-Knock J; Cotman C; Cras P; Cruts M; De Deyn PP; Decarli C; Dobson-Stone C; Engelborghs S; Fox N; Galasko D; Gearing M; Gijselinck I; Grafman J; Hartikainen P; Hatanpaa KJ; Highley JR; Hodges J; Hulette C; Ince PG; Jin LW; Kirby J; Kofler J; Kril J; Kwok JBJ; Levey A; Lieberman A; Llado A; Martin JJ; Masliah E; McDermott CJ; McKee A; McLean C; Mead S; Miller CA; Miller J; Munoz DG; Murrell J; Paulson H; Piguet O; Rossor M; Sanchez-Valle R; Sano M; Schneider J; Silbert LC; Spina S; Van Der Zee J; Van Langenhove T; Warren J; Wharton SB; White CL; Woltjer RL; Trojanowski JQ; Lee VMY; Van Deerlin V; Chen-Plotkin AS, 2014, 'TMEM106B is a genetic modifier of frontotemporal lobar degeneration with C9orf72 hexanucleotide repeat expansions', Acta Neuropathologica, 127, pp. 407 - 418, http://dx.doi.org/10.1007/s00401-013-1239-x

Shine JM; O'Callaghan C; Halliday GM; Lewis SJG, 2014, 'Tricks of the mind: Visual hallucinations as disorders of attention', Progress in Neurobiology, 116, pp. 58 - 65, http://dx.doi.org/10.1016/j.pneurobio.2014.01.004

McCann H; Stevens CH; Cartwright H; Halliday GM, 2014, 'α-Synucleinopathy phenotypes', Parkinsonism and Related Disorders, 20, http://dx.doi.org/10.1016/S1353-8020(13)70017-8

Schwartz R; Halliday G; Cordato D; Kril J, 2014, '2.', Journal of Clinical Neuroscience, 21, pp. 2033 - 2033, http://dx.doi.org/10.1016/j.jocn.2014.06.016

Coupland KG; Mellick GD; Silburn PA; Mather K; Armstrong NJ; Sachdev PS; Brodaty H; Huang Y; Halliday GM; Hallupp M; Kim WS; Dobson-Stone C; Kwok JBJ; Kim W; Schofield P, 2014, 'DNA methylation of the MAPT gene in Parkinson's disease cohorts and modulation by vitamin E In Vitro', Movement Disorders, 29, pp. 1606 - 1614, http://dx.doi.org/10.1002/mds.25784

Wong JH; Halliday GM; Kim WS, 2014, 'Exploring myelin dysfunction in multiple system atrophy.', Exp Neurobiol, 23, pp. 337 - 344, http://dx.doi.org/10.5607/en.2014.23.4.337

Halliday G, 2014, 'F4‐02‐01: IDENTIFYING THE DYNAMICS OF LEWY BODY FORMATION IN LEWY BODY DISEASES', Alzheimer's & Dementia, 10, http://dx.doi.org/10.1016/j.jalz.2014.04.367

Po K; Leslie FVC; Gracia N; Bartley L; Kwok JBJ; Halliday GM; Hodges JR; Burrell JR, 2014, 'Heritability in frontotemporal dementia: more missing pieces?', Journal of Neurology, 261, pp. 2170 - 2177, http://dx.doi.org/10.1007/s00415-014-7474-9

Coupland K; Kim WS; Halliday G; Dobson‐Stone C; Kwok JBJ, 2014, 'P1‐039: MAPT METHYLATION IN ALZHEIMER'S DISEASE', Alzheimer's & Dementia, 10, http://dx.doi.org/10.1016/j.jalz.2014.05.274

Bleasel JM; Hsiao JHT; Halliday GM; Kim WS, 2013, 'Increased expression of ABCA8 in multiple system atrophy brain is associated with changes in pathogenic proteins', Journal of Parkinson's Disease, 3, pp. 331 - 339, http://dx.doi.org/10.3233/JPD-130203

Cheshire P; Bertram K; Ling H; O'Sullivan SS; Halliday G; McLean C; Bras J; Foltynie T; Storey E; Williams DR, 2013, 'Influence of single nucleotide polymorphisms in COMT, MAO-A and BDNF genes on dyskinesias and levodopa use in Parkinson's disease', Neurodegenerative Diseases, 13, pp. 24 - 28, http://dx.doi.org/10.1159/000351097

Kemp S; Harding AJ; Halliday GM; Mahant N; Fung VSC, 2013, 'Cortical limb myoclonus in pathologically proven progressive supranuclear palsy', Movement Disorders, 28, pp. 1804 - 1806, http://dx.doi.org/10.1002/mds.25693

Mills JD; Kavanagh T; Kim WS; Chen BJ; Kawahara Y; Halliday GM; Janitz M, 2013, 'Unique Transcriptome Patterns of the White and Grey Matter Corroborate Structural and Functional Heterogeneity in the Human Frontal Lobe', PLoS ONE, 8, http://dx.doi.org/10.1371/journal.pone.0078480

Wang JH; Gouda-Vossos A; Dzamko N; Halliday G; Huang Y, 2013, 'DNA extraction from fresh-frozen and formalin-fixed, paraffinembedded human brain tissue', Neuroscience Bulletin, 29, pp. 649 - 654, http://dx.doi.org/10.1007/s12264-013-1379-y

Dang TNT; Dobson-Stone C; Glaros EN; Kim WS; Hallupp M; Bartley L; Piguet O; Hodges JR; Halliday GM; Double KL; Schofield PR; Crouch PJ; Kwok JBJ; Kim W; Schofield P, 2013, 'Endogenous progesterone levels and frontotemporal dementia: Modulation of TDP-43 and Tau levels in vitro and treatment of the A315T TARDBP mouse model', DMM Disease Models and Mechanisms, 6, pp. 1198 - 1204, http://dx.doi.org/10.1242/dmm.011460

Zhou JX; Zhang HB; Huang Y; He Y; Zheng Y; Anderson JP; Gai WP; Liang ZG; Wang Y; Ren XM; Wang Q; Gong XL; Yang J; Wang X; Halliday G; Wang XM, 2013, 'Tenuigenin attenuates α-synuclein-induced cytotoxicity by down-regulating polo-like kinase 3', CNS Neuroscience and Therapeutics, 19, pp. 688 - 694, http://dx.doi.org/10.1111/cns.12124

Reyes S; Cottam V; Kirik D; Double KL; Halliday GM, 2013, 'Variability in neuronal expression of dopamine receptors and transporters in the substantia nigra', Movement Disorders, 28, pp. 1351 - 1359, http://dx.doi.org/10.1002/mds.25493

Hsiao JHT; Fu YH; Hill AF; Halliday GM; Kim WS, 2013, 'Elevation in Sphingomyelin Synthase Activity Is Associated with Increases in Amyloid-Beta Peptide Generation', PLoS ONE, 8, http://dx.doi.org/10.1371/journal.pone.0074016

Dzamko N; Chua G; Ranola M; Rowe DB, 2013, 'Measurement of LRRK2 and Ser910/935 phosphorylated LRRK2 in peripheral blood mononuclear cells from idiopathic Parkinson's disease patients', Journal of Parkinson's Disease, 3, pp. 145 - 152, http://dx.doi.org/10.3233/JPD-130174

Dzamko N; Halliday GM, 2013, 'Unlocking the secrets of LRRK2 function with selective kinase inhibitors', Future Neurology, 8, pp. 347 - 357, http://dx.doi.org/10.2217/fnl.13.9

Nalls MA; Duran R; Lopez G; Kurzawa-Akanbi M; McKeith IG; Chinnery PF; Morris CM; Theuns J; Crosiers D; Cras P; Engelborghs S; De Deyn PP; Van Broeckhoven C; Mann DMA; Snowden J; Pickering-Brown S; Halliwell N; Davidson Y; Gibbons L; Harris J; Sheerin UM; Bras J; Hardy J; Clark L; Marder K; Honig LS; Berg D; Maetzler W; Brockmann K; Gasser T; Novellino F; Quattrone A; Annesi G; De Marco EV; Rogaeva E; Masellis M; Black SE; Bilbao JM; Foroud T; Ghetti B; Nichols WC; Pankratz N; Halliday G; Lesage S; Klebe S; Durr A; Duyckaerts C; Brice A; Giasson BI; Trojanowski JQ; Hurtig HI; Tayebi N; Landazabal C; Knight MA; Keller M; Singleton AB; Wolfsberg TG; Sidransky E, 2013, 'A multicenter study of glucocerebrosidase mutations in dementia with Lewy bodies', JAMA Neurology, 70, pp. 727 - 735, http://dx.doi.org/10.1001/jamaneurol.2013.1925

Kordower JH; Olanow CW; Dodiya HB; Chu Y; Beach TG; Adler CH; Halliday GM; Bartus RT, 2013, 'Disease duration and the integrity of the nigrostriatal system in Parkinson's disease', Brain, 136, pp. 2419 - 2431, http://dx.doi.org/10.1093/brain/awt192

Halliday GM, 2013, 'Motor deficits associated with changes in β-amyloid in Parkinson's disease', Journal of Neurology, Neurosurgery and Psychiatry, 84, pp. 475 - 476, http://dx.doi.org/10.1136/jnnp-2012-304177

Ravenscroft TA; Baker MC; Rutherford NJ; Neumann M; Mackenzie IR; Josephs KA; Boeve BF; Petersen R; Halliday GM; Kril J; van Swieten JC; Seeley WW; Dickson DW; Rademakers R, 2013, 'Mutations in protein N-arginine methyltransferases are not the cause of FTLD-FUS', Neurobiology of Aging, 34, pp. 2235.e11 - 2235.e13, http://dx.doi.org/10.1016/j.neurobiolaging.2013.04.004

Tan RH; Pok K; Wong S; Brooks D; Halliday GM; Kril JJ, 2013, 'The pathogenesis of cingulate atrophy in behavioral variant frontotemporal dementia and Alzheimer's disease', Acta neuropathologica communications, 1, pp. 30, http://dx.doi.org/10.1186/2051-5960-1-30

Kim WS; Hsiao JT; Bhatia S; Glaros E; Don AS; Tsuruoka S; Shannon Weickert CS; Halliday GM, 2013, 'ABCA8 stimulates sphingomyelin production in oligodendrocytes', Biochemical Journal, 452, pp. 401 - 410, http://dx.doi.org/10.1042/BJ20121764

Abbott SK; Jenner AM; Mitchell T; Brown S; Halliday GM; Garner B, 2013, 'An Improved High-Throughput lipid extraction method for the analysis of human brain lipids', Lipids, 48, pp. 307 - 318, http://dx.doi.org/10.1007/s11745-013-3760-z

Kragh CL; Fillon G; Gysbers A; Hansen HD; Neumann M; Richter-Landsberg C; Haass C; Zalc B; Lubetzki C; Gai WP; Halliday GM; Kahle PJ; Jensen PH, 2013, 'FAS-Dependent Cell Death in á-Synuclein Transgenic Oligodendrocyte Models of Multiple System Atrophy', PLoS ONE, 8, pp. Article numbere 55243, http://dx.doi.org/10.1371/journal.pone.0055243

Dobson-Stone C; Luty A; Thompson EM; Blumbergs P; Brooks WS; Short CL; Field C; Panegyres P; Hecker J; Solski JA; Blair I; Fullerton JM; Halliday GM; Schofield PR; Kwok J; Schofield P, 2013, 'Frontotemporal dementia-amyotrophic lateral sclerosis syndrome locus on chromosome 16p12.1-q12.2: Genetic, clinical and neuropathological analysis', ACTA Neuropathologica, 125, pp. 523 - 533, http://dx.doi.org/10.1007/s00401-013-1078-9

Davies KM; Hare DJ; Cottam V; Chen N; Hilgers L; Halliday GM; Mercer JFB; Double KL, 2013, 'Localization of copper and copper transporters in the human brain', Metallomics, 5, pp. 43 - 51, http://dx.doi.org/10.1039/c2mt20151h

Guerreiro PS; Huang Y; Gysbers A; Cheng D; Gai WP; Outeiro TF; Halliday GM, 2013, 'LRRK2 interactions with α-synuclein in Parkinson’s disease brains and in cell models', Journal of Molecular Medicine - Jmm, 91, pp. 513 - 522, http://dx.doi.org/10.1007/s00109-012-0984-y

Tan RH; Wong S; Hodges JR; Halliday GM; Hornberger M, 2013, 'Retrosplenial Cortex (BA 29) Volumes in Behavioral Variant Frontotemporal Dementia and Alzheimer's Disease', Dementia and Geriatric Cognitive Disorders, 35, pp. 177 - 182, http://dx.doi.org/10.1159/000346392

Reyes S; Fu Y; Double KL; Cottam V; Thomp LH; Kirik D; Paxinos G; Watson C; Cooper HM; Halliday GM, 2013, 'Trophic factors differentiate dopamine neurons vulnerable to Parkinson's disease', Neurobiology of Aging, 34, pp. 873 - 886, http://dx.doi.org/10.1016/j.neurobiolaging.2012.07.019

Thanos SM; Halliday GM; Damian DL, 2012, 'Nicotinamide reduces photodynamic therapy-induced immunosuppression in humans', BRITISH JOURNAL OF DERMATOLOGY, 167, pp. 631 - 636, http://dx.doi.org/10.1111/j.1365-2133.2012.11109.x

Sarchio SNE; Kok L-F; O'Sullivan C; Halliday GM; Byrne SN, 2012, 'Dermal mast cells affect the development of sunlight-induced skin tumours', EXPERIMENTAL DERMATOLOGY, 21, pp. 241 - 248, http://dx.doi.org/10.1111/j.1600-0625.2012.01438.x

Huang Y; Chegini F; Chua G; Murphy K; Gai W; Halliday GM, 2012, 'Macroautophagy in sporadic and the genetic form of Parkinson's disease with the A53T α-synuclein mutation', Translational Neurodegeneration, 1, http://dx.doi.org/10.1186/2047-9158-1-2

Fu Y; Yuan Y; Halliday GM; Rusznak Z; Watson C; Paxinos G, 2012, 'A cytoarchitectonic and chemoarchitectonic analysis of the dopamine cell groups in the substantia nigra, ventral tegmental area, and retrorubral field in the mouse', Brain Structure and Function, 217, pp. 591 - 612, http://dx.doi.org/10.1007/s00429-011-0349-2

Wong J; Higgins M; Halliday GM; Garner B, 2012, 'Amyloid beta selectively modulates neuronal TrkB alternative transcript expression with implications for Alzheimer's disease', Neuroscience, 210, pp. 363 - 374, http://dx.doi.org/10.1016/j.neuroscience.2012.02.037

Lewis SJG; Shine JM; Duffy S; Halliday GM; Naismith SL, 2012, 'Anterior cingulate integrity: Executive and neuropsychiatric features in Parkinson's disease', Movement Disorders, 27, pp. 1262 - 1267, http://dx.doi.org/10.1002/mds.25104

Huang Y; Halliday GM, 2012, 'Aspects of innate immunity and Parkinson's disease', Frontiers in Pharmacology, 3, pp. Art. No. 33, http://dx.doi.org/10.3389/fphar.2012.00033

Dobson-Stone C; Hallupp M; Bartley L; Shepherd CE; Halliday GM; Schofield PR; Hodges JR; Kwok J, 2012, 'C9ORF72 repeat expansion in clinical and neuropathological frontotemporal dementia cohorts', Neurology, 79, pp. 995 - 1001

Kim WS; Halliday , 2012, 'Changes in sphingomyelin level affect alpha-synuclein and ABCA5 expression', Journal of Parkinson's Disease, 2, pp. 41 - 46, http://dx.doi.org/10.3233/JPD-2012-11059

Halliday GM; Mccann H; Shepherd CE, 2012, 'Evaluation of the Braak hypothesis: how far can it explain the pathogenesis of Parkinson's disease?', Expert Review of Neurotherapeutics, 12, pp. 673 - 686, http://dx.doi.org/10.1586/ern.12.47

Reyes S; Fu Y; Double KL; Thompson L; Kirik D; Paxinos G; Halliday GM, 2012, 'GIRK2 expression in dopamine neurons of the substantia nigra and ventral tegmental area', Journal of Comparative Neurology, 520, pp. 2591 - 2607, http://dx.doi.org/10.1002/cne.23051

Hornberger M; Wong S; Tan R; Irish M; Piguet O; Kril J; Hodges JR; Halliday GM, 2012, 'In vivo and post-mortem memory circuit integrity in frontotemporal dementia and Alzheimer's disease', Brain, 135, pp. 3015 - 3025, http://dx.doi.org/10.1093/brain/aws239

Shine JM; Halliday GM; Carlos M; Lewis SJG; Naismith S, 2012, 'Investigating visual misperceptions in Parkinson's disease: A novel behavioral paradigm', Movement Disorders, 27, pp. 500 - 505, http://dx.doi.org/10.1002/mds.24900

Sharpe LJ; Wong J; Garner B; Halliday GM; Brown AJ, 2012, 'Is seladin-1 really a selective Alzheimer's disease indicator?', Journal of Alzheimer's Disease, 30, pp. 35 - 39, http://dx.doi.org/10.3233/JAD-2012-111955

Elliott DA; Kim WS; Gorissen SV; Halliday GM; Kwok J, 2012, 'Leucine-rich repeat kinase 2 and alternative splicing in Parkinson's disease', Movement Disorders, 27, pp. 1004 - 1011, http://dx.doi.org/10.1002/mds.25005

Halliday GM; Bigio EH; Cairns NJ; Neumann M; Mackenzie IRA; Mann DM, 2012, 'Mechanisms of disease in frontotemporal lobar degeneration: Gain of function versus loss of function effects', ACTA Neuropathologica, 124, pp. 373 - 382, http://dx.doi.org/10.1007/s00401-012-1030-4

Valenzuela MJ; Matthews F; Brayne C; Ince P; Halliday GM; Kril J; Dalton M; Richardson K; Forster G; Sachdev PS, 2012, 'Multiple Biological Pathways Link Cognitive Lifestyle to Protection from Dementia', Biological Psychiatry, 71, pp. 783 - 791, http://dx.doi.org/10.1016/j.biopsych.2011.07.036

Back to profile page